1. Market Research
  2. > Healthcare
  3. > Health Services Market Trends
Hallux Valgus (Bunion) - Epidemiology Forecast to 2030

Hallux Valgus (Bunion) - Epidemiology Forecast to 2030

  • October 2020
  • 80 pages
  • ID: 6025288
  • Format: PDF
  • Delve Insight

Summary

Table of Contents

‘Hallux Valgus (Bunion) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Hallux Valgus (Bunion) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Hallux Valgus (Bunion) Understanding
Hallux valgus, commonly known as a Bunion, is one of the most common progressive forefoot deformities across the globe. A bunion is basically a “bump” which develops at the joint of the big toe—the metatarsophalangeal (MTP) joint. The big toe is made up of two joints. The larger of the two is the MTP, where the first long bone of the foot (metatarsal) meets the first bone of the toe (phalanx). Bump formation happens slowly over long period of time and finally progresses when the bone or tissue at the big toe joint moves out of alignment. Many women wear tight, narrow shoes that squeeze the toes together, creating favorable conditions for a bunion to develop, deteriorate, and cause painful symptoms. Apart from wearing tight-narrow shoes, heredity and other inflammatory condition, such as rheumatoid arthritis or a neuromuscular condition, such as polio, cause bunion in an individual. Clinically, bunions are classified into three types, mild, moderate, and severe. Hallux valgus severity can be defined as the angulation of the big toe at the first metatarsophalangeal joint and classified as mild (20°–30°), moderate (30°–40°) and severe (>40°). Bunions can occur in any gender or age group, but they are most commonly observed in women and the elderly.

Epidemiology Perspective
The Hallux Valgus (Bunion) epidemiology division provides insights about historical and current patient pool and forecasted trends for each seven major countries. The Hallux Valgus epidemiology data are studied through Hallux Valgus possible division to give a better understanding of the Disease scenario in the 7MM.
The disease epidemiology covered in the report provides historical as well as forecasted Hallux Valgus (Bunion) epidemiology [segmented as Total Prevalent Cases of Hallux Valgus (by Age), Total Diagnosed Prevalent Cases of Hallux Valgus, Severity-specific Prevalent Cases of Hallux Valgus, Severity-specific Prevalent Cases of Hallux Valgus, Treated cases of Hallux Valgus] in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017 to 2030.

Hallux Valgus (Bunion) Detailed Epidemiology Segmentation
• In the year 2017, the total prevalent cases of Hallux Valgus were 172,039,751 in the 7MM. In the 7MM, among all the age groups 11,973,464 cases were accounted for less than 18 years, whereas for the age group 18–65 years and more than 65 years accounted for 109,690,287 and 50,376,000 number of cases for the year 2017.
• The United States, in 2017, accounted for 70,259,180 cases (the highest number among the 7MM countries).
• Among the EU-5 countries, the highest number of cases of Hallux Valgus were in Germany, i.e., 18,748,873 cases in the year 2017, which is estimated to rise by the year 2030.
• In the 7MM, in 2017 diagnosed Hallux Valgus prevalent cases accounted for 137,631,801 in 2017.
• The risk of hallux valgus is 2 to 3-fold higher in females compared to males. In the 7MM, the total gender-specific prevalent cases of Hallux Valgus was 41,609,614 for males and 96,022,186 for females in the year 2017
• Among the 7MM, Japan accounted for 28,351,056, prevalent cases in 2017.
• In the 7MM, 91,249,883 mild Hallux Valgus cases were observed in 2017. For moderate and severe Hallux Valgus type, 37,435,850 and 8,946,067 number of cases were observed in 2017, respectively.

Scope of the Report
• The Hallux Valgus report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns.
• The Hallux Valgus Report and Model provide an overview of the risk factors and global trends of Hallux Valgus in the seven major markets (7MM: United States, Germany, France, Italy, Spain, and the United Kingdom, and Japan).
• The report provides insight about the historical and forecasted patient pool of Hallux Valgus in seven major markets covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
• The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.
• The report assesses the disease risk and burden and highlights the unmet needs of Hallux Valgus .
• The report provides the segmentation of the Hallux Valgus epidemiology by Total Prevalent Cases of Hallux Valgus (by Age) in the 7MM.
• The report provides the segmentation of the Hallux Valgus epidemiology by Total Diagnosed Prevalent Cases in the 7MM.
• The report provides the segmentation of the Hallux Valgus epidemiology by Gender-specific Prevalent Cases of Hallux Valgus in the 7MM.
• The report provides the segmentation of the Hallux Valgus epidemiology by Severity-specific Prevalent Cases of Hallux Valgus in the 7MM.
• The report provides the segmentation of the Hallux Valgus epidemiology by Treated Cases of Hallux Valgus in the 7MM.

Report Highlights

• 11-Year Forecast Of Hallux Valgus Epidemiology
• 7MM Coverage
• Total Prevalent Cases of Hallux Valgus (by Age) in the 7MM
• Total Diagnosed Prevalent Cases of Hallux Valgus in the 7MM.
• Gender-specific Prevalent Cases of Hallux Valgus in the 7MM.
• Severity-specific Prevalent Cases of Hallux Valgus in the 7MM.
• Treated cases of Hallux Valgus in the 7MM.
KOL-Views
We interview, KOL’s and SME’s opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the over Hallux Valgus scenario of the indications.

Key Questions Answered
• What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Hallux Valgus?
• What are the key findings pertaining to the Hallux Valgus epidemiology across the 7MM and which country will have the highest number of patients during the study period (2017–2030)?
• What would be the total number of patients of Hallux Valgus across the 7MM during the study period (2017–2030)?
• Among the EU5 countries, which country will have the highest number of patients during the study period (2017–2030)?
• At what CAGR the patient population is expected to grow in the 7MM during the study period (2017–2030)?
• What are the various recent and upcoming events which are expected to improve the diagnosis of Hallux Valgus?

Reasons to buy
The Hallux Valgus Epidemiology report will allow the user to -
• Develop business strategies by understanding the trends shaping and driving the global Hallux Valgus market
• Quantify patient populations in the global Hallux Valgus market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Hallux Valgus therapeutics in each of the markets covered
• Understand the magnitude of Hallux Valgus population by its severity
• The Hallux Valgus epidemiology report and model were written and developed by Masters and PhD level epidemiologists
• The Hallux Epidemiology Model developed is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments
• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Geographies Covered
• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan
Study Period: 2017–2030

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Bronchopulmonary Dysplasia - Epidemiology Forecast to 2030

  • $ 5500
  • February 2021
  • 225 pages

‘Bronchopulmonary Dysplasia (BPD) – Epidemiology Forecast—2030’ report delivers an in-depth understanding of the BPD, historical and forecasted epidemiology in the United States, EU5 (Germany, ...

  • World
  • Spain
  • Epidemiology
  • Industry analysis

ref:plp2020

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on